Research Article
Comparing Medium-Term Clinical Outcomes following XEN® 45 and XEN® 63 Device Implantation
| | | XEN® 45 | XEN® 63 |
| | Number eyes | 40 | 34 | | Gender (female/male) (%) | 57.5/42.5 | 56/44 | | Eyes (OD/OS) | 22/18 | 22/12 | | Age (years) | 77.31 ± 6.33 (65 to 89) | 73.36 ± 8.83 (55 to 85) | | Combined surgery (cataract + glaucoma) (%) | 80.0 | 94.1 |
|
|
